Basic Aspects of Ghrelin Action

Vitamins and Hormones

Volumn 77, Issue , 2007, Pages 89-119

  Pazos, Yolanda ^a,b   Casanueva, Felipe F ^b,c   Camiña, Jesus P ^a,c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GROWTH HORMONE; GROWTH HORMONE SECRETAGOGUE RECEPTOR;

ANIMAL; CHEMISTRY; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; MOUSE; PHYSIOLOGY; RAT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENERGY METABOLISM; GHRELIN; GROWTH HORMONE; HOMEOSTASIS; HUMANS; MICE; RATS; RECEPTORS, GHRELIN; SIGNAL TRANSDUCTION;

EID: 35648972136     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(06)77005-4     Document Type: Review

References (149)

1. Abizaid A., Liu Z.W., Andrews Z.B., Shanab rough M., Borok E., Elsworth J.D., Roth R.H., Sleeman M.W., Picciotto M.R., Tschop M.H., Gao X.B., and Horvath T.L. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 116 12 (2006) 3229-3239
2. Adams E.F., Petersen B., Lei T., Buchfelder M., and Fahlbusch R. The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors. Biochem. Biophys. Res. Commun. 208 (1995) 555-561
3. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., Carling D., and Small C.J. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279 (2004) 12005-12008
4. Andreis P.G., Malendowicz L.K., Trejter M., Neri G., Spinazzi R., Rossi G.P., and Nussdorfer G.G. Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells. FEBS Lett. 536 (2003) 17317-17319
5. Ariyasu H., Takaya K., Iwakura H., Hosoda H., Akamizu T., Arai Y., Kangawa K., and Nakao K. Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 146 (2005) 355-364
6. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Ueno N., Makino S., Fujimiya M., Niijima A., Fujino M.A., and Kasuga M. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120 (2001) 337-345
7. Asakawa A., Inui A., Fujimiya M., Sakamaki R., Shinfuku N., Ueta Y., Meguid M.M., and Kasuga M. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 54 (2005) 18-24
8. Avallone R., Demers A., Rodrigue-Way A., Bujold K., Harb D., Anghel S., Wahli W., Marleau S., Ong H., and Tremblay A. A Growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor upregulates ABC sterol transporters and cholesterol efflux in macrophages through a PPAR{gamma}-dependent pathway. Mol. Endocrinol. 20 (2006) 3165-3178
9. Baiguera S., Conconi M.T., Guidolin D., Mazzocchi G., Malendowicz L.K., Parnigotto P.P., Spinazzi R., and Nussdorfer G.G. Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells. Int. J. Mol. Med. 14 (2004) 849-854
10. Baldanzi G., Filigheddu N., Cutrupi S., Catapano F., Bonissoni S., Fubini A., Malan D., Baj G., Granata R., Broglio F., Papotti M., Surico N., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 159 (2002) 1029-1037
11. Barazzoni R., Bosutti A., Stebel M., Cattin M.R., Roder E., Visintin L., Cattin L., Biolo G., Zanetti M., and Guarnieri G. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E228-E235
12. Bedendi I., Alloatti G., Marcantoni A., Malan D., Catapano F., Ghe C., Deghenghi R., Ghigo E., and Muccioli G. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur. J. Pharmacol. 476 (2003) 87-95
13. Bednarek M.A., Feighner S.D., Pong S.S., McKee K.K., Hreniuk D.L., Silva M.V., Warren V.A., Howard A.D., Van Der Ploeg L.H., and Heck J.V. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43 (2000) 4370-4376
14. Bennett P.A., Thomas G.B., Howard A.D., Feighner S.D., van der Ploeg L.H., Smith R.G., and Robinson I.C. Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 138 (1997) 4552-4557
15. Bodart V., Febbraio M., Demers A., McNicoll N., Pohankova P., Perreault A., Sejlitz T., Escher E., Silverstein R.L., Lamontagne D., and Ong H. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ. Res. 90 (2002) 844-849
16. Bondensgaard K., Ankersen M., Thogersen H., Hansen B.S., Wulff B.S., and Bywater R.P. Recognition of privileged structures by G-protein coupled receptors. J. Med. Chem. 47 (2004) 888-899
17. Bowers C.Y., Momany F., Reynolds G.A., Chang D., Hong A., and Chang K. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 10 (1980) 663-667
18. Bowers C.Y., Momany F.A., Reynolds G.A., and Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114 (1984) 1537-1545
19. Bresciani E., Nass R., Torsello A., Gaylinn B., Avallone R., Locatelli V., Thorner M.O., and Muller E.E. Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites. Neuroendocrinology 80 (2004) 52-59
20. Broglio F., Arvat E., Benso A., Gotero C., Muccioli G., Papotti M., van der Lely A.J., Deghenghi R., and Ghigo E. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J. Clin. Endocrinol. Metab. 86 (2001) 5083-5086
21. Brywe K.G., Leverin A.L., Gustavsson M., Mallard C., Granata R., Destefanis S., Volante M., Hagberg H., Ghigo E., and Isgaard J. Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3β phosphorylation. Endocrinology 146 (2005) 4665-4672
22. Calapai G., Corica F., Allegra A., Corsonello A., Sautebin L., De Gregorio T., Di Rosa M., Costantino G., Buemi M., and Caputi A.P. Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse. Br. J. Pharmacol. 125 (1998) 798-802
23. Calapai G., Corica F., Corsonello A., Sautebin L., Di Rosa M., Campo G.M., Buemi M., Mauro V.N., and Caputi A.P. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J. Clin. Invest. 104 (1999) 975-982
24. Camina J.P., Carreira M.C., El Messari S., Llorens-Cortes C., Smith R.G., and Casanueva F.F. Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a. Endocrinology 145 (2004) 930-940
25. Caminos J.E., Gualillo O., Lago F., Otero M., Blanco M., Gallego R., Garcia-Caballero T., Goldring M.B., Casanueva F.F., Gomez-Reino J.J., and Dieguez C. The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology 146 (2005) 1285-1292
26. Carreira M.C., Camina J.P., Smith R.G., and Casanueva F.F. Agonist-specific coupling of growth hormone secretagogue receptor type 1a to different intracellular signaling systems. Role of adenosine. Neuroendocrinology 79 (2004) 13-25
27. Carreira M.C., Camina J.P., Diaz-Rodriguez E., Alvear-Perez R., Llorens-Cortes C., and Casanueva F.F. Adenosine does not bind to the growth hormone secretagogue receptor type-1a (GHS-R1a). J. Endocrinol. 191 (2006) 147-157
28. Cassoni P., Papotti M., Ghe C., Catapano F., Sapino A., Graziani A., Deghenghi R., Reissmann T., Ghigo E., and Muccioli G. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab. 84 (2001) 1738-1745
29. Cassoni P., Ghe C., Marrocco T., Tarabra E., Allia E., Catapano F., Deghenghi R., Ghigo E., Papotti M., and Muccioli G. Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines. Eur. J. Endocrinol. 150 (2004) 173-184
30. Castrillo A., and Tontonoz P. Nuclear receptors in macrophage biology: At the crossroads of lipid metabolism and inflammation. Annu. Rev. Cell Dev. Biol. 20 (2004) 455-480
31. 2+ permeability in cultured ovine somatotrophs. J. Neuroendocrinol. 7 (1995) 179-186
32. Chen C., Zhang J., Vincent J.D., and Israel J.M. Two types of voltage-dependent calcium current in rat somatotrophs are reduced by somatostatin. J. Physiol. 425 (1990) 29-42
33. Chen C., Wu D., and Clarke I.J. Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J. Endocrinol. 148 (1996) 381-386
34. Chen C.Y., Inui A., Asakawa A., Fujino K., Kato I., Chen C.C., Ueno N., and Fujimiya M. Des-acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats. Gastroenterology 129 (2005) 8-25
35. Conconi M.T., Nico B., Guidolin D., Baiguera S., Spinazzi R., Rebuffat P., Malendowicz L.K., Vacca A., Carraro G., Parnigotto P.P., Nussdorfer G.G., and Ribatti D. Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo. Peptides 25 (2004) 2179-2185
36. Cunha S.R., and Mayo K.E. Ghrelin and growth hormone (GH) secretagogues potentiate GH-releasing hormone (GHRH)-induced cyclic adenosine 3′,5′-monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors. Endocrinology 143 (2002) 4570-4582
37. Dass N.B., Munonyara M., Bassil A.K., Hervieu G.J., Osbourne S., Corcoran S., Morgan M., and Sanger G.J. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience 120 (2003) 443-453
38. Deghenghi R., Papotti M., Ghigo E., and Muccioli G. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J. Endocrinol. Invest. 24 (2001) RC1-RC3
39. Delgado-Rubin de Celix A., Chowen J.A., Argente J., and Frago L.M. Growth hormone releasing peptide-6 acts as a survival factor in glutamate-induced excitotoxicity. J. Neurochem. 99 (2006) 839-849
40. Delhanty P.J., van der Eerden B.C., van der Velde M., Gauna C., Pols H.A., Jahr H., Chiba H., van der Lely A.J., and van Leeuwen J.P. Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a. J. Endocrinol. 188 (2006) 37-47
41. De Vriese C., Gregoire F., De Neef P., Robberecht P., and Delporte C. Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation. Endocrinology 146 (2005) 1514-1522
42. Dixit V.D., Schaffer E.M., Pyle R.S., Collins G.D., Sakthivel S.K., Palaniappan R., Lillard Jr. J.W., and Tabú D.D. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Invest. 114 (2004) 57-66
43. Dumont J.E., Pecasse F., and Maenhaut C. Crosstalk and specificity in signalling. Are we crosstalking ourselves into general confusion?. Cell. Signal. 13 (2001) 457-463
44. Duxbury M.S., Waseem T., Ito H., Robinson M.K., Zinner M.J., Ashley S.W., and Whang E.E. Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness. Biochem. Biophys. Res. Commun. 309 (2003) 464-468
45. Druce M.R., Wren A.M., Park A.J., Milton J.E., Patterson M., Frost G., Ghatei M.A., Small C., and Bloom S.R. Ghrelin increases food intake in obese as well as lean subjects. Int. J. Obes. (Lond.) 29 (2005) 1130-1136
46. Feighner S.D., Howard A.D., Prendergast K., Palyha O.C., Hreniuk D.L., Nargund R., Underwood D., Tata J.R., Dean D.C., Tan C.P., McKee K.K., Woods J.W., et al. Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol. Endocrinol. 12 (1998) 137-145
47. Frago L.M., Paneda C., Dickson S.L., Hewson A.K., Argente J., and Chowen J.A. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology 143 (2002) 4113-4122
48. Frago L.M., Paneda C., Argente J., and Chowen J.A. Growth hormone-releasing peptide-6 increases insulin-like growth factor-I mRNA levels and activates Akt in RCA-6 cells as a model of neuropeptide Y neurones. J. Neuroendocrinol. 17 (2005) 701-710
49. Gauna C., Meyler F.M., Janssen J.A., Delhanty P.J., Abribat T., van Koetsveld P., Hofland L.J., Broglio F., Ghigo E., and van der Lely A.J. Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J. Clin. Endocrinol. Metab. 89 (2004) 5035-5042
50. Gauna C., Delhanty P.J., Hofland L.J., Janssen J.A., Broglio F., Ross R.J., Ghigo E., and van der Lely A.J. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J. Clin. Endocrinol. Metab. 90 (2005) 1055-1060
51. Gaskin F.S., Farr S.A., Banks W.A., Kumar V.B., and Morley J.E. Ghrelin-induced feeding is dependent on nitric oxide. Peptides 24 (2003) 913-918
52. Gaytan F., Barreiro M.L., Chopin L.K., Herington A.C., Morales C., Pinilla L., Casanueva F.F., Aguilar E., Dieguez C., and Tena-Sempere M. Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J. Clin. Endocrinol. Metab. 88 (2003) 879-887
53. Gaytan F., Barreiro M.L., Caminos J.E., Chopin L.K., Herington A.C., Morales C., Pinilla L., Paniagua R., Nistal M., Casanueva F.F., Aguilar E., Dieguez C., et al. Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J. Clin. Endocrinol. Metab. 89 (2004) 400-409
54. Gaytan F., Morales C., Barreiro M.L., Jeffery P., Chopin L.K., Herington A.C., Casanueva F.F., Aguilar E., Dieguez C., and Tena-Sempere M. Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives and ovarian tumors. J. Clin. Endocrinol. Metab. 90 (2005) 1798-17804
55. Ghe C., Cassoni P., Catapano F., Marrocco T., Deghenghi R., Ghigo E., Muccioli G., and Papotti M. The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells. Endocrinology 143 (2002) 484-491
56. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., and Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 87 (2002) 2988-2991
57. Granado M., Priego T., Martín A.I., Villanua M.A., and Lopez-Calderon A. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E1007-E10014
58. Grove K.L., and Cowley M.A. Is ghrelin a signal for the development of metabolic systems?. J. Clin. Invest. 115 (2005) 3393-3397
59. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., Smith R.G., Van der Ploeg L.H., and Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 48 (1997) 23-29
60. Hardie D.G. The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell. Sci. 117 (2004) 5479-5487
61. Herrington J., and Hille B. Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms. Endocrinology 135 (1994) 1100-1108
62. Holst B., and Schwartz T.W. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol. Sci. 25 (2004) 113-117
63. Holst B., and Schwartz T.W. Ghrelin receptor mutations-too little height and too much hunger. J. Clin. Invest. 116 (2006) 637-641
64. Holst B., Cygankiewicz A., Jensen T.H., Ankersen M., and Schwartz T.W. High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol. Endocrinol. 17 (2003) 2201-2210
65. Holst B., Holliday N.D., Bach A., Elling C.E., Cox H.M., and Schwartz T.W. Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem. 279 (2004) 53806-53817
66. Holst B., Brandt E., Bach A., Heding A., and Schwartz T.W. Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling. Mol. Endocrinol. 19 (2005) 2400-2411
67. Holst B., Lang M., Brandt E., Bach A., Howard A., Frimurer T.M., Beck-Sickinger A., and Schwartz T.W. Ghrelin receptor inverse agonists: Identification of an active peptide core and its interaction epitopes on the receptor. Mol. Pharmacol. 70 (2006) 936-946
68. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996) 974-977
69. Horikawa R., Tachibana T., Katsumata N., Ishikawa H., and Tanaka T. Regulation of pituitary growth hormone-secretagogue and growth hormone-releasing hormone receptor RNA expression in young Dwarf rats. Endocr. J. 47 (2000) S53-S56
70. Iglesias M.J., Pineiro R., Blanco M., Gallego R., Dieguez C., Gualillo O., Gonzalez-Juanatey J.R., and Lago F. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc. Res. 62 (2004) 481-488
71. Jeffery P.L., Herington A.C., and Chopin L.K. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J. Endocrinol. 172 (2002) R7-R11
72. Jiang H., Betancourt L., and Smith R.G. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol. Endocrinol. 20 (2006) 1772-1785
73. Johansson S., Fredholm B.B., Hjort C., Morein T., Kull B., and Hu P.S. Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor. Biochem. Pharmacol. 70 (2005) 598-605
74. Kaji H., Kishimoto M., Kirimura T., Iguchi G., Murata M., Yoshioka S., Iida K., Okimura Y., Yoshimoto Y., and Chihara K. Hormonal regulation of the human ghrelin receptor gene transcription. Biochem. Biophys. Res. Commun. 284 (2001) 660-666
75. Kamegai J., Wakabayashi I., Miyamoto K., Unterman T.G., Kineman R.D., and Frohman L.A. Growth hormone-dependent regulation of pituitary GH secretagogue receptor (GHS-R) mRNA levels in the spontaneous dwarf rat. Neuroendocrinology 68 (1998) 312-318
76. Kamegai J., Wakabayashi I., Kineman R.D., and Frohman L.A. Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats. J. Neuroendocrinol. 11 (1999) 299-306
77. Kamegai J., Tamura H., Ishii S., Sugihara H., and Wakabayashi I. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. J. Neuroendocrinol. 13 (2001) 275-278
78. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., and Oikawa S. Insulin-like growth factor-I down-regulates ghrelin receptor (growth hormone secretagogue receptor) expression in the rat pituitary. Regul. Pept. 127 (2005) 203-206
79. Katayama M., Nogami H., Nishiyama J., Kawase T., and Kawamura K. Developmentally and regionally regulated expression of growth hormone secretagogue receptor mRNA in rat brain and pituitary gland. Neuroendocrinology 72 (2000) 333-340
80. + concentration of rat pituitary cells in primary culture. J. Neuroendocrinol. 11 (1999) 795-800
81. Kim M.S., Yoon C.Y., Jang P.G., Park Y.J., Shin C.S., Park H.S., Ryu J.W., Pak Y.K., Park J.Y., Lee K.U., Kim S.Y., Lee H.K., et al. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol. Endocrinol. 18 (2004) 2291-2301
82. Kineman R.D., Kamegai J., and Frohman L.A. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. Endocrinology 140 (1999) 3581-3586
83. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
84. Kojima M., Hosoda H., Matsuo H., and Kangawa K. Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 12 (2001) 118-122
85. Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., Williams L.M., Hawley S.A., Hardie D.G., Grossman A.B., and Korbonits M. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J. Biol. Chem. 280 (2005) 25196-25201
86. 2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52 (2003) 948-956
87. Korbonits M., Goldstone A.P., Gueorguiev M., and Grossman A.B. Ghrelin: A hormone with multiple functions. Front. Neuroendocrinol. 25 (2004) 27-68
88. Laferrere B., Abraham C., Russell C.D., and Bowers C.Y. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J. Clin. Endocrinol. Metab. 90 (2005) 611-614
89. Lee C.H., Chawla A., Urbiztondo N., Liao D., Boisvert W.A., Evans R.M., and Curtiss L.K. Transcriptional repression of atherogenic inflammation: Modulation by PPARdelta. Science 302 (2003) 453-457
90. Li W.G., Gavrila D., Liu X., Wang L., Gunnlaugsson S., Stoll L.L., McCormick M.L., Sigmund C.D., Tang C., and Weintraub N.L. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 109 (2004) 2221-2226
91. Long Y.C., and Zierath J.R. AMP-activated protein kinase signaling in metabolic regulation. J. Clin. Invest. 116 (2006) 1776-1783
92. Luttrell L.M., and Lefkowitz R.J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell. Sci. 115 (2002) 455-465
93. Maccarinelli G., Sibilia V., Torsello A., Raimondo F., Pitto M., Giustina A., Netti C., and Cocchi D. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J. Endocrinol. 184 (2005) 249-256
94. Mazzocchi G., Neri G., Rucinski M., Rebuffat P., Spinazzi R., Malendowicz L.K., and Nussdorfer G.G. Ghrelin enhances the growth of cultured human adrenal zona glomerulosa cells by exerting MAPK-mediated proliferogenic and antiapoptotic effects. Peptides 25 (2004) 1269-1277
95. McKee K.K., Palyha O.C., Feighner S.D., Hreniuk D.L., Tan C.P., Phillips M.S., Smith R.G., Van der Ploeg L.H., and Howard A.D. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol. Endocrinol. 11 (1997) 415-423
96. Morley J.E., Alshaher M.M., Farr S.A., Flood J.F., and Kumar V.B. Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: Further evidence for a role of nitric oxide in feeding. Peptides 20 (1999) 595-600
97. Mousseaux D., Le Gallic L., Ryan J., Oiry C., Gagne D., Fehrentz J.A., Galleyrand J.C., and Martinez J. Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway. Br. J. Pharmacol. 148 (2006) 350-365
98. Muccioli G., Ghe C., Ghigo M.C., Papotti M., Arvat E., Boghen M.F., Nilsson M.H., Deghenghi R., Ong H., and Ghigo E. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 157 (1998) 99-106
99. Muccioli G., Papotti M., Locatelli V., Ghigo E., and Deghenghi R. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J. Endocrinol. Invest. 24 (2001) RC7-RC9
100. Muccioli G., Pons N., Ghe C., Catapano F., Granata R., and Ghigo E. Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor. Eur. J. Pharmacol. 498 (2004) 27-35
101. Murata M., Okimura Y., Iida K., Matsumoto M., Sowa H., Kaji H., Kojima M., Kangawa K., and Chihara K. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J. Biol. Chem. 277 (2002) 5667-5674
102. Nakazato M., Murakami N., Date Y., Kojima M., Matsuo H., Kangawa K., and Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
103. Nagaya N., Moriya J., Yasumura Y., Uematsu M., Ono F., Shimizu W., Ueno K., Kitakaze M., Miyatake K., and Kangawa K. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110 (2004) 3674-3679
104. Nass R., Gilrain J., Anderson S., Gaylinn B., Dalkin A., Day R., Peruggia M., and Thorner M.O. High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary. Endocrinology 141 (2000) 2084-2089
105. Neary N.M., Small C.J., Wren A.M., Lee J.L., Druce M.R., Palmieri C., Frost G.S., Ghatei M.A., Combes R.C., and Bloom S.R. Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 89 (2004) 2832-2836
106. Nogueiras R., Tovar S., Mitchell S.E., Rayner D.V., Archer Z.A., Dieguez C., and Williams L.M. Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes 53 (2004) 2552-2558
107. Ong H., McNicoll N., Escher E., Collu R., Deghenghi R., Locatelli V., Ghigo E., Muccioli G., Boghen M., and Nilsson M. Identification of a pituitary growth hormone-releasing peptide (GHRP) receptor subtype by photoaffinity labeling. Endocrinology 139 (1998) 432-435
108. Pantel J., Legendre M., Carbol S., Hilal L., Hajaji Y., Moriste S., Nivot S., Vie-Luton M.P., Grouselle D., de Kerdanet M., Kadiri A., Epelbaum J., et al. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J. Clin. Invest. 116 (2006) 760-768
109. Patchett A.A., Nargund R.P., Tata J.R., Chen M.H., Barakat K.J., Johnston D.B., Cheng K., Chan W.W., Butler B., Hickey G., Jacks T., Schleim K., et al. Design and biological activities of L-163,191 (MK-0677): A potent, orally active growth hormone secretagogue. Proc. Natl. Acad. Sci. USA 92 (1995) 7001-7005
110. Pedretti A., Villa M., Pallavicini M., Valoti E., and Vistoli G. Construction of human ghrelin receptor (hGHS-R1a) model using a fragmental prediction approach and validation through docking analysis. J. Med. Chem. 49 (2006) 3077-3085
111. Peng X.-D., Park S., Gadelha M.R., Coschigano K.C., Kopchick K.C., and Frohman K.C. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: Hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback. Endocrinology 142 (2001) 1117-1123
112. Petersenn S., Rasch A.C., Penshorn M., Beil F.U., and Schulte H.M. Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology 142 (2001) 2649-2659
113. Qader S.S., Lundquist I., Ekelund M., Hakanson R., and Salehi A. Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release. Regul. Pept. 128 (2005) 51-56
114. Rossi F., Bertone C., Petricca S., and Santiemma V. Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells. Atherosclerosis 192 2 (2006) 291-297
115. Schmid D.A., Held K., Ising M., Uhr M., Weikel J.C., and Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 30 (2005) 1187-1192
116. Shimada M., Tritos N.A., Lowell B.B., Flier J.S., and Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396 (1998) 670-674
117. Shuto Y., Shibasaki T., Otagiri A., Kuriyama H., Ohata H., Tamura H., Kamegai J., Sugihara H., Oikawa S., and Wakabayashi I. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J. Clin. Invest. 109 (2002) 1429-1436
118. Smith R.G., Cheng K., Schoen W.R., Pong S.S., Hickey G., Jacks T., Butler B., Chan W.W., Chaung L.Y., Judith F., Taylor J., Wyvratt J., et al. A nonpeptidyl growth hormone secretagogue. Science 260 (1993) 1640-1643
119. Smith R.G., Griffin P.R., Xu Y., Smith A.G., Liu K., Calacay J., Feighner S.D., Pong C., Leong D., Pomes A., Cheng K., Van der Ploeg L.H., et al. Adenosine: A partial agonist of the growth hormone secretagogue receptor. Biochem. Biophys. Res. Commun. 276 (2000) 1306-1313
120. Smith R.G., Jiang H., and Sun Y. Developments in ghrelin biology and potential clinical relevance. Trends Endocrinol. Metab. 16 (2005) 436-442
121. Sun Y., Ahmed S., and Smith R.G. Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell Biol. 23 (2003) 7973-7981
122. Sun Y., Wang P., Zheng H., and Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA 101 (2004) 4679-4684
123. Tannenbaum G.S., Lapointe M., Beaudet A., and Howard A.D. Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 139 (1998) 4420-4423
124. Tamura H., Kamegai J., Sugihara H., Kineman R.D., Frohman L.A., and Wakabayashi I. Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. J. Neuroendocrinol. 12 (2000) 481-485
125. Thomas G.B., Bennett P.A., Carmignac D.F., and Robinson I.C. Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat. Growth Horm. IGF Res. 10 (2000) 45-52
126. Thompson N.M., Gill D.A., Davies R., Loveridge N., Houston P.A., Robinson I.C., and Wells T. Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 145 (2004) 234-242
127. Torsello A., Ghe C., Bresciani E., Catapano F., Ghigo E., Deghenghi R., Locatelli V., and Muccioli G. Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo. Endocrinology 143 (2002) 1968-1971
128. Toshinai K., Yamaguchi H., Sun Y., Smith R.G., Yamanaka A., Sakurai T., Date Y., Mondal M.S., Shimbara T., Kawagoe T., Murakami N., Miyazato M., et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147 (2006) 2306-2314
129. Tullin S., Hansen B.S., Ankersen M., Moller J., Von Cappelen K.A., and Thim L. Adenosine is an agonist of the growth hormone secretagogue receptor. Endocrinology 141 (2000) 3397-3402
130. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
131. van der Lely A.J., Tschop M., Heiman M.L., and Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev. 25 (2004) 426-457
132. Wallenius K., Sjögren K., Peng X.D., Park S., Wallenius V., and Liu V. Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology 142 (2001) 114762-114770
133. Wang H.J., Geller F., Dempfle A., Schauble N., Friedel S., Lichtner P., Fontenla-Horro F., Wudy S., Hagemann S., Gortner L., Huse K., Remschmidt H., et al. Ghrelin receptor gene: Identification of several sequence variants in extremely obese children and adolescents, healthy
134. Welch J.S., Ricote M., Akiyama T.E., Gonzalez F.J., and Glass C.K. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc. Natl. Acad. Sci. USA 100 (2003) 6712-6717
135. Willesen M.G., Kristensen P., and Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70 (1999) 306-316
136. Wortley K.E., Anderson K.D., Garcia K., Murria J.D., Malinova L., Liu R., Moncrieffe M., Thabet K., Cox H.J., Yancopoulos G.D., Wiegand S.J., and Sleeman M.W. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc. Natl. Acad. Sci. USA 101 (2004) 8227-8232
137. Wortley K.E., del Rincón J.P., Murria J.D., Garcia K., Iida K., Thorner M.O., and Sleeman M.W. Absence of ghrelin protects against early-onset obesity. J. Clin. Invest. 115 (2005) 3573-3578
138. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G., Ghatei M.A., and Bloom S.R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
139. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., and Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86 (2001) 5992-5995
140. Wren A.M., Small C.J., Abbott C.R., Dhillo W.S., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., and Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes 50 (2001) 2540-2547
141. Wu D., Chen C., Zhang J., Bowers C.Y., and Clarke I.J. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3′,5′-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs. J. Endocrinol. 148 (1996) 197-205
142. Wynne K., Giannitsopoulou K., Small C.J., Patterson M., Frost G., Ghatei M.A., Brown E.A., Bloom S.R., and Choi P. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: A randomized, placebo-controlled trial. J. Am. Soc. Nephrol. 16 (2005) 2111-2118
143. Xie Q.F., Wu C.X., Meng Q.Y., and Li N. Ghrelin and truncated ghrelin variant plasmid vectors administration into skeletal muscle augments long-term growth in rats. Domest. Anim. Endocrinol. 27 (2004) 155-164
144. Zhao D., Keates A.C., Kuhnt-Moore S., Moyer M.P., Kelly C.P., and Pothoulakis C. Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes. J. Biol. Chem. 276 (2001) 44464-44471
145. Zhao D., Zhan Y., Zeng H., Koon H.W., Moyer M.P., and Pothoulakis C. Neurotensin stimulates interleukin-8 expression through modulation of I kappa. B alpha phosphorylation and p65 transcriptional activity: Involvement of protein kinase C alpha. Mol. Pharmacol. 67 (2005) 2025-2031
146. Zhao D., Zhan Y., Zeng H., Moyer M.P., Mantzoros C.S., and Pothoulakis C. Ghrelin stimulates interleukin-8 gene expression through protein kinase C-mediated NF-kappaB pathway in human colonic epithelial cells. J. Cell Biochem. 97 (2006) 1317-1327
147. Zhou Y., Xu B.C., Maheshwari H.G., He L., Reed M., and Lozykowski M. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl. Acad. Sci. USA 94 (1997) 13215-13220
148. Zigman J.M., Nakano Y., Coppari R., Baltasar N., Marcus J.N., Lee C.E., Jones J.E., Deysher A.E., Waxman A.R., White R.D., Williams T.D., Lachey J.L., et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J. Clin. Invest. 115 (2005) 3564-3572
149. Zhu X., Cao Y., Voodg K., and Steiner D.F. On the processing of proghrelin to ghrelin. J. Biol. Chem. 281 (2006) 38867-38870